News
Pharma giant Gilead Sciences agreed to pay hundreds of millions of dollars to state health insurance programs after admitting ...
Gilead Sciences Inc. settled for $202 million over illegal kickbacks for HIV drug prescriptions, following Attorney General Raoul's lead with a multi-state coalition.
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
Gilead Sciences will pay more than $200 million after admitting to a multi-year illegal kickback scheme that pushed its HIV drugs through lavish perks for prescribers. New York Attorney General ...
CHICAGO Attorney General Kwame Raoul, as part of a bipartisan coalition of 49 attorneys general, announced a $202 million multistate settlement agreement ...
"Government health care dollars are precious and must be used without favor in order to achieve the highest possible health ...
Explore more
Massachusetts AG Campbell secures $1.6 million for the state's Medicaid in a settlement with Gilead over illegal kickbacks ...
StockStory.org on MSN21h
Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics SegmentAs the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
20h
Gulf Business on MSNGilead’s Vítor Papão on key partnerships and the role of tech in public healthGilead's Papao shares insights on the evolving role of public-private collaboration in healthcare, and how emerging tech is ...
The scheme involved incentives to healthcare providers, leading to false claims to government programs like Medicaid.
Gilead Sciences Inc. closed 9.09% short of its 52-week high of $119.96, which the company achieved on March 10th.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results